CellTrials.org COVID-19 Clinical Trials


Through the end of November 2020, 156 trials have been registered worldwide that propose to prevent or treat COVID-19 or related conditions with cell therapy. For each trial, the excel file holds:

  • Month (there were no cell therapy trials registered in January)
  • Year (always 2020)
  • Trial ID with link to trial on-line
  • Country where registered
  • Trial Phase
  • Cell Types that are active ingredients
  • Patient Indication
  • Expected Enrollment of the trial
  • Sponsor names
  • Notes on trial name or product name (optional)

Inclusions/Exclusions: We are only tracking cell therapy clinical trials for COVID-19. (Previous versions of this database tracked all trials of COVID-19 treatments.) This database only holds officially registered clinical trials.

>> Watch the News blog of this website or follow @celltrialsdata on Twitter for graphs summarizing features of these trials.

>> Read our poster abstract published (open access) at Stem Cells Translational Medicine giving an overview of the first half of 2020. Here is a slide from our presentation at Cord Blood Connect 2020 covering the first half of 2020:

Role of immunotherapy in cell therapy trials for COVID-19

>> Citations: If you use this data in a publication or presentation, please acknowledge the Team at CellTrials.org

>> Specific Questions: This data was compiled by Pedro Silva Couto, and most of the graphs were made by Frances Verter.

>> Want more insights? CellTrials.org offers monthly or quarterly subscriptions to all advanced cell therapy clinical trials that provides twice as much data per trial, for all international trials for any indication.

Public samples: